Ameritas Investment Partners, Inc. Vbi Vaccines Inc Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	BUY	$2.77 - $6.17 $2,770 - $6,170	1,000 Added 7.63%	14,103 $40,000
Q1 2020 May 13, 2020	BUY	$0.73 - $1.91 $4,161 - $10,887	5,700 Added 77.0%	13,103 $12,000
Q2 2019 Aug 14, 2019	BUY	$0.65 - $2.12 $4,811 - $15,694	7,403 New	7,403 $9,000
Q2 2018 Aug 13, 2018	SELL	$2.75 - $3.85 $5,236 - $7,330	-1,904 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	1,904	1,904 $8,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.